The next cycle of evolution in the business and economics of healthcare transcends with market integration. Outcomes become markets. “Value” becomes new system vision.

It can be defined in different ways, but at its heart is the production of not just new products and services, but new outcomes. How these outcomes are produced, how they are shared across an economic system, and what is done with the earnings that are created from their production (reinvestment) are questions that sit at the center of pharmaceutical market strategy positioned on creating ‘system value’.